UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis

Nature communications, 2020-09, Vol.11 (1), p.4767-4767, Article 4767

2020

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2023-02, Vol.75 (2), p.253-265

2023

Link zum Volltext

Verfügbarkeit prüfen

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates

Communications biology, 2021-12, Vol.4 (1), p.1395-1395, Article 1395

2021

Link zum Volltext

Verfügbarkeit prüfen

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Proceedings of the National Academy of Sciences - PNAS, 2015-08, Vol.112 (34), p.10768-10773

2015

Link zum Volltext

Verfügbarkeit prüfen

Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis

Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.901-914

2016

Link zum Volltext

Verfügbarkeit prüfen

Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele

Nature communications, 2019-10, Vol.10 (1), p.4575-11, Article 4575

2019

Link zum Volltext

Verfügbarkeit prüfen

Persistent stromal fibroblast activation is present in chronic tendinopathy

Arthritis research & therapy, 2017-01, Vol.19 (1), p.16-16, Article 16

2017

Link zum Volltext

Verfügbarkeit prüfen

LBO1 DORIS remission in patients with SLE treated with anifrolumab or placebo during the 4-year TULIP-LTE trial: post hoc analysis

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A169-A170

2024

Link zum Volltext

Verfügbarkeit prüfen

Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study design

Trials, 2021-03, Vol.22 (1), p.185-185, Article 185

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting DORIS Remission and LLDAS in SLE: A Review

Rheumatology and therapy., 2023-12, Vol.10 (6), p.1459-1477

2023

Link zum Volltext

Verfügbarkeit prüfen

Novel Therapeutic Targets in Axial Spondyloarthritis

Current treatment options in rheumatology, 2018, Vol.4 (2), p.174-182

2018

Link zum Volltext

Verfügbarkeit prüfen

Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply

Annals of the rheumatic diseases, 2014-04, Vol.73 (4), p.763-770

2014

Link zum Volltext

Verfügbarkeit prüfen

Nothing about us without us: involving patient collaborators for machine learning applications in rheumatology

Annals of the rheumatic diseases, 2021-12, Vol.80 (12), p.1505

2021

Link zum Volltext

Verfügbarkeit prüfen

Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce

Nature reviews. Rheumatology, 2023-09, Vol.19 (9), p.592-602

2023

Link zum Volltext

Verfügbarkeit prüfen

The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource

Pediatric rheumatology online journal, 2023-07, Vol.21 (1), p.70-70, Article 70

2023

Link zum Volltext

Verfügbarkeit prüfen

The long-term safety and tolerability of anifrolumab for patients with systemic lupus erythematosus in Japan: TULIP-LTE subgroup analysis

Modern rheumatology, 2023-09

2023

Link zum Volltext

Verfügbarkeit prüfen

Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis

Annals of the rheumatic diseases, 2016-05, Vol.75 (5), p.916-923

2016

Link zum Volltext

Verfügbarkeit prüfen

Correction: Targeting DORIS Remission and LLDAS in SLE: A Review

Rheumatology and therapy., 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the genetic determinants of context-specific DNA methylation in primary monocytes

Cell genomics, 2024-05, Vol.4 (5), p.100541-100541, Article 100541

2024

Link zum Volltext

Verfügbarkeit prüfen

Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohortsResearch in context

EBioMedicine, 2024-02, Vol.100, p.104946

2024

Link zum Volltext

Verfügbarkeit prüfen

Precision medicine in psoriatic arthritis: how should we select targeted therapies?

The Lancet. Rheumatology, 2019-09, Vol.1 (1), p.e66-e73

2019

Link zum Volltext

Verfügbarkeit prüfen

Pathogenic immune responses in spondyloarthritis

Al-Mossawi, Mohammad Hussein

2016

Link zum Volltext
ProQuest

The Clinical Role of Glucocorticoids in the Management of Rheumatoid Arthritis

Al-Mossawi, Hussein

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Sprache

Englisch
(24)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis

A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis

Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele

Persistent stromal fibroblast activation is present in chronic tendinopathy

LBO1 DORIS remission in patients with SLE treated with anifrolumab or placebo during the 4-year TULIP-LTE trial: post hoc analysis

Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis

Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study design

Targeting DORIS Remission and LLDAS in SLE: A Review

Novel Therapeutic Targets in Axial Spondyloarthritis

Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply

Nothing about us without us: involving patient collaborators for machine learning applications in rheumatology

Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce

The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource

The long-term safety and tolerability of anifrolumab for patients with systemic lupus erythematosus in Japan: TULIP-LTE subgroup analysis

Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis

Correction: Targeting DORIS Remission and LLDAS in SLE: A Review

Characterization of the genetic determinants of context-specific DNA methylation in primary monocytes

Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohortsResearch in context

Precision medicine in psoriatic arthritis: how should we select targeted therapies?

Pathogenic immune responses in spondyloarthritis

The Clinical Role of Glucocorticoids in the Management of Rheumatoid Arthritis

Aktive Filter

Suchergebnisse filtern